» Articles » PMID: 19171504

Lipidomic Analysis of Endocannabinoid Metabolism in Biological Samples

Overview
Publisher Elsevier
Date 2009 Jan 28
PMID 19171504
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

The endocannabinoids are signaling lipids present in many living organisms. They activate G protein-coupled cannabinoid receptors to modulate a broad range of biological processes that include emotion, cognition, inflammation and reproduction. The endocannabinoids are embedded in an interconnected network of cellular lipid pathways, the regulation of which is likely to control the strength and duration of endocannabinoid signals. Therefore, physiopathological or pharmacological perturbations of these pathways may indirectly affect endocannabinoid activity and, vice versa, endocannabinoid activity may influence lipid pathways involved in other metabolic and signaling events. Recent progress in liquid chromatography and mass spectrometry has fueled the development of targeted lipidomic approaches, which allow researchers to examine complex lipid interactions in cells and gain a broader view of the endocannabinoid system. Here, we review these new developments from the perspective of our laboratory's experience in the field.

Citing Articles

Metabolomics, Lipidomics, and Antipsychotics: A Systematic Review.

Burghardt K, Kajy M, Ward K, Burghardt P Biomedicines. 2023; 11(12).

PMID: 38137517 PMC: 10741000. DOI: 10.3390/biomedicines11123295.


Pan-phylum Analyses of Nematode Endocannabinoid Signalling Systems Highlight Novel Opportunities for Parasite Drug Target Discovery.

Crooks B, McKenzie D, Cadd L, McCoy C, McVeigh P, Marks N Front Endocrinol (Lausanne). 2022; 13:892758.

PMID: 35846343 PMC: 9283691. DOI: 10.3389/fendo.2022.892758.


Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine.

Greco R, Demartini C, Zanaboni A, Francavilla M, Reggiani A, Realini N J Headache Pain. 2022; 23(1):79.

PMID: 35799128 PMC: 9264488. DOI: 10.1186/s10194-022-01449-1.


Endocannabinoids as potential biomarkers: It's all about pre-analytics.

Kratz D, Thomas D, Gurke R J Mass Spectrom Adv Clin Lab. 2021; 22:56-63.

PMID: 34939056 PMC: 8662329. DOI: 10.1016/j.jmsacl.2021.11.001.


Sample Preparation Methods for Lipidomics Approaches Used in Studies of Obesity.

Liakh I, Sledzinski T, Kaska L, Mozolewska P, Mika A Molecules. 2020; 25(22).

PMID: 33203044 PMC: 7696154. DOI: 10.3390/molecules25225307.


References
1.
McKinney M, Cravatt B . Structure and function of fatty acid amide hydrolase. Annu Rev Biochem. 2005; 74:411-32. DOI: 10.1146/annurev.biochem.74.082803.133450. View

2.
Moody J, Kozak K, Ji C, Marnett L . Selective oxygenation of the endocannabinoid 2-arachidonylglycerol by leukocyte-type 12-lipoxygenase. Biochemistry. 2001; 40(4):861-6. DOI: 10.1021/bi002303b. View

3.
Oka S, Tsuchie A, Tokumura A, Muramatsu M, Suhara Y, Takayama H . Ether-linked analogue of 2-arachidonoylglycerol (noladin ether) was not detected in the brains of various mammalian species. J Neurochem. 2003; 85(6):1374-81. DOI: 10.1046/j.1471-4159.2003.01804.x. View

4.
King A, Duranti A, Tontini A, Rivara S, Rosengarth A, Clapper J . URB602 inhibits monoacylglycerol lipase and selectively blocks 2-arachidonoylglycerol degradation in intact brain slices. Chem Biol. 2007; 14(12):1357-65. PMC: 2225625. DOI: 10.1016/j.chembiol.2007.10.017. View

5.
Wei B, Mikkelsen T, McKinney M, Lander E, Cravatt B . A second fatty acid amide hydrolase with variable distribution among placental mammals. J Biol Chem. 2006; 281(48):36569-78. DOI: 10.1074/jbc.M606646200. View